Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CD38 | P28907 | 8/20 | 0.85 |
| ▸ | DPP4 | P27487 | 2/20 | 0.61 |
| ▸ | MAOA | P21397 | 1/20 | 0.61 |
| ▸ | F2 | P00734 | 1/20 | 0.57 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.57 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.57 |
| ▸ | GLO1 | Q04760 | 5/20 | 0.56 |
| ▸ | SNCA | P37840 | 3/20 | 0.56 |
| ▸ | OR51E2 | Q9H255 | 2/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
| ▸ | EGFR | P00533 | 2/20 | 0.46 |
| ▸ | KDR | P35968 | 2/20 | 0.46 |
| ▸ | EP300 | Q09472 | 2/20 | 0.46 |
| ▸ | CREBBP | Q92793 | 2/20 | 0.46 |
| ▸ | MAOB | P27338 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | FYN | P06241 | 1/20 | 0.43 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Peonidin SCHEMBL20017 | 0.92 | CD38 (1.00) | CD38DPP4MAOAF2NR1H2 | |
| Peonidin SCHEMBL30891536 | 0.92 | CD38 (1.00) | CD38DPP4MAOAF2NR1H2 | |
| Peonidin SCHEMBL29394353 | 0.92 | CD38 (1.00) | CD38DPP4MAOAF2NR1H2 | |
| Peonidin SCHEMBL29403736 | 0.90 | CD38 (0.97) | CD38DPP4MAOAF2NR1H2 | |
| Peonidin SCHEMBL20016 | 0.90 | CD38 (0.97) | CD38DPP4MAOAF2NR1H2 | |
| Peonidin SCHEMBL2560105 | 0.89 | CD38 (0.95) | CD38DPP4MAOAF2NR1H2 | |
| SCHEMBL29435846 | 0.86 | CD38 (0.84) | CD38DPP4MAOAF2NR1H2 | |
| SCHEMBL7527028 | 0.86 | CD38 (0.84) | CD38DPP4MAOAF2NR1H2 | |
| Petunidin SCHEMBL8500875 | 0.83 | CD38 (0.82) | CD38DPP4MAOAF2NR1H2 | |
| Malvidin SCHEMBL8504053 | 0.81 | CD38 (0.83) | CD38DPP4MAOAF2NR1H2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 212 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260033519-A1 | STORAGE-STABLE BEVERAGES COMPRISING ANTHOCYANINS | BOARD OF TRUSTEES OF SOUTHERN ILLINOIS UNIV (US) | 2026-02-05 | — | — | US | claimed |
| EP-4622686-A1 | SPRAY PATCH COMPOSITION, PROCESS FOR PREPARING IT AND KIT | Fondazione Istituto Italiano di Tecnologia (IT) | 2025-10-01 | — | — | EP | claimed |
| WO-2024191124-A1 | ENZYMATIC ELECTRODE AND ENZYMATIC BIOFUEL CELL INCLUDING SAME | 서울과학기술대학교 산학협력단 | 2024-09-19 | — | — | WO | claimed |
| WO-2024110911-A1 | SPRAY PATCH COMPOSITION, PROCESS FOR PREPARING IT AND KIT | FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA (IT) | 2024-05-30 | — | — | WO | claimed |
| US-11834560-B2 | Water degradable film containing hyaluronic acid or salt thereof and polyphenol compounds | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2023-12-05 | — | — | US | claimed |
| US-20230355769-A1 | COMPOSITIONS, CONTAINERS, AND METHODS RELATED TO FLAVYLIUM EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2023-11-09 | — | — | US | claimed |
| US-20230338331-A1 | COMPOSITIONS, CONTAINERS, AND METHODS RELATED TO FLAVYLIUM EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2023-10-26 | — | — | US | claimed |
| EP-3573748-B1 | COLOURED ORGANIC/INORGANIC HYBRID MATERIALS AND METHOD FOR PREPARING SAME | CENTRE NAT RECH SCIENT (FR) | 2023-04-19 | — | — | EP | claimed |
| US-11577063-B2 | Soluble microneedle containing ingredient for controlling release of neurotransmitters | LG HOUSEHOLD & HEALTH CARE LTD. (KR) | 2023-02-14 | — | — | US | claimed |
| EP-4043037-A1 | CELLULAR HYDRATION COMPOSITIONS CONTAINING CYCLODEXTRINS | Eastpond Laboratories Limited (GB) | 2022-08-17 | — | — | EP | claimed |
| WO-2026100079-A1 | PHOTOSENSITIVE RESIN COMPOSITION, CURED PRODUCT, PATTERNED CURED PRODUCT PRODUCTION METHOD, AND ELECTRONIC COMPONENT | ＨＤマイクロシステムズ株式会社 | 2026-05-15 | — | — | WO | disclosed |
| WO-2026100734-A1 | PHOTOSENSITIVE RESIN COMPOSITION, CURED PRODUCT, PATTERNED CURED PRODUCT PRODUCTION METHOD, AND ELECTRONIC COMPONENT | ＨＤマイクロシステムズ株式会社 | 2026-05-15 | — | — | WO | disclosed |
| EP-4740961-A2 | CANNABINOID PRODUCT FOR IMPROVING MUSCULOSKELETAL HEALTH | Lonza Greenwood LLC (US) | 2026-05-13 | — | — | EP | disclosed |
| EP-4734923-A1 | CLEANSING COMPOSITIONS COMPRISING DIVALENT SALTS | L'OREAL (FR) | 2026-05-06 | — | — | EP | disclosed |
| EP-4037503-B1 | CANNABINOID PRODUCT FOR IMPROVING MUSCULOSKELETAL HEALTH | LONZA GREENWOOD LLC (US) | 2026-04-29 | — | — | EP | disclosed |
| US-11278475-B2 | Personal care composition | WEIDMANN HOLDING AG (CH) | 2022-03-22 | — | — | US | disclosed |
| EP-3950910-A1 | WATER-SOLUBLE ADDITIVE COMPOSITION | Sumitomo Bakelite Co.Ltd. (JP) | 2022-02-09 | — | — | EP | disclosed |
| WO-2022025598-A1 | COMPOSITION FOR INDUCING DIFFERENTIATION FROM PLURIPOTENT STEM CELLS INTO MESENCHYMAL STEM CELLS COMPRISING SMAD1/5/8 ACTIVATOR AND USE THEREOF | 삼성전자 주식회사 | 2022-02-03 | — | — | WO | disclosed |
| US-20220031602-A1 | SKIN PERFECTING COSMETIC COMPOSITIONS AND METHODS OF USE | L'OREAL (FR) | 2022-02-03 | — | — | US | disclosed |
| US-11234940-B1 | Method for making a noble metal nanomedicine | KING ABDULAZIZ UNIVERSITY (SA) | 2022-02-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230355769-A1 | COMPOSITIONS, CONTAINERS, AND METHODS RELATED TO FLAVYLIUM EXCIPIENTS | CNR2, CNR1, UGT8 | CD38 2308/4885DPP4 4789/4885MAOA 831/4885 |
| US-20230338331-A1 | COMPOSITIONS, CONTAINERS, AND METHODS RELATED TO FLAVYLIUM EXCIPIENTS | CNR2, CNR1, UGT8 | CD38 2308/4885DPP4 4789/4885MAOA 831/4885 |
| US-20260033519-A1 | STORAGE-STABLE BEVERAGES COMPRISING ANTHOCYANINS | SIRT1, SIRT3, CRY1 | CD38 1428/4885DPP4 2439/4885MAOA 597/4885 |
| US-20220031602-A1 | SKIN PERFECTING COSMETIC COMPOSITIONS AND METHODS OF USE | CUTA, DSG1, SMURF1 | CD38 4131/4885DPP4 4841/4885MAOA 3720/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.